SPDR S&P Biotech ETF
193 hedge funds and large institutions have $3.95B invested in SPDR S&P Biotech ETF in 2015 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 52 increasing their positions, 68 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
7% more funds holding
Funds holding: 180 → 193 (+13)
24% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 68
67% less call options, than puts
Call options by funds: $689M | Put options by funds: $2.06B
Holders
193
Holding in Top 10
11
Calls
$689M
Puts
$2.06B
Top Buyers
| 1 | +$190M | |
| 2 | +$189M | |
| 3 | +$136M | |
| 4 |
Citigroup
New York
|
+$75.1M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$53.6M |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$12M | |
| 3 | -$4.84M | |
| 4 |
LRPA
L. Roy Papp & Associates
Phoenix,
Arizona
|
-$3.95M |
| 5 |
VCAM
Valentine Capital Asset Management
Danville,
California
|
-$3.03M |